CYTONET GMBH

The Cytonet Group is an international biotechnology company with sites in Weinheim, Germany and Durham, NC, USA. Cytonet has 60 employees and develops and produces cell-therapeutic products which could offer alternatives for existant therapies, e.g. organ transplantation. In order to provide a cellular medicinal product for the treatment of urea cycle defects, cells from donated but non-transplantable livers are gently isolated and processed in a complex procedure developed by Cytonet. Managi... ng directors are Dr. Wolfgang Rรผdinger and Dipl.-Kfm. Michael J. Deissner. Cytonet was founded by a demerger from the Roche Group in April 2000. The Dietmar Hopp family owns the majority of shares. The SELICA study on liver cell therapy as a treatment for inborn errors of liver metabolism in neonates and infants is currently ongoing in Germany and the USA
CYTONET GMBH
Industry:
Biotechnology Health Care
Founded:
2000-01-01
Address:
Weinheim, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.cytonet.de
Total Employee:
51+
Status:
Active
Contact:
49 6201 2598 0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Font Awesome Apache IPv6 Apache 2.4 Hetzner Debian
Similar Organizations
Current Advisors List
Official Site Inspections
http://www.cytonet.de
- Host name: 159.89.214.161
- IP address: 159.89.214.161
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313

More informations about "Cytonet GmbH"
Cytonet GmbH - Crunchbase Company Profile & Funding
The Cytonet Group is an international biotechnology company with sites in Weinheim, Germany and Durham, NC, USA. Cytonet has 60 employees and โฆSee details»
Cytonet GmbH & Co. KG | LinkedIn
Cytonet GmbH & Co. KG | 342 followers on LinkedIn. The Cytonet Group is an international biotech company which currently has 55 employees at the company sites in Weinheim/Germany, Heidelberg ...See details»
Cytonet Company Profile 2025: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Cytonet. Use the PitchBook Platform to explore the full profile.See details»
Cytonet GmbH & Co. KG: Contact Details and Business Profile
Cytonet GmbH & Co. KG is a Biotechnology, Business Services, and Liver Cell Therapy company_reader located in Weinheim, Baden-Wuerttemberg with $3 million in revenue and 3 โฆSee details»
Cytonet GmbH & Co KG - Weinheim, Deutschland - bionity.com
Aug 27, 2008 Die Cytonet-Gruppe ist auf dem Gebiet der medizinischen Biotechnologie tätig. Sie entwickelt, produziert und vermarktet neue, zellbasierte, medizinische Produkte. Partner โฆSee details»
Cytonet GmbH & Co KG - Weinheim, Germany - bionity.com
About Cytonet The Cytonet Group is an international biotech company which currently has 55 employees at the company sites in Weinheim/Germany, Heidelberg/Germany and Durham, โฆSee details»
Cytonet - Company Profile - Tracxn
Jan 17, 2025 The Cytonet Group is a German biotechnology company that develops and produces cell therapeutic products. The company has developed a cell therapy treatment for โฆSee details»
Interview with Wolfgang Rüdinger, CEO, Cytonet
Sep 21, 2009 Cytonet lacked know-how in regulatory affairs and clinical trials; thus, it had to strengthen its capacities in these important fields. Traditionally, biotech companies start with โฆSee details»
Cytonet - VentureRadar
"Cytonet, founded by a demerger from Boehringer Mannheim in 2000 develops, produces and markets cell-therapeutic products that offer alternatives for extant therapies, e.g. organ โฆSee details»
Organization | Cytonet GmbH & Co. KG - Purdue University
Cytonet GmbH & Co. KG Report issue For profit Phase 2 Founded: Weinheim Germany (2000) Status: Acquired by Promethera Biosciences (2016) Organization Overview First Clinical TrialSee details»
Cytonet GmbH & Co. KG Overview | SignalHire Company Profile
The Cytonet Group is an international biotech company which currently has 55 employees at the company sites in Weinheim/Germany, Heidelberg/Germany and Durham, North Carolina/USA. โฆSee details»
Cytonet GmbH & Co. KG - life-sciences-europe.com
Apr 1, 2000 To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«See details»
Cytonet Hannover GmbH - Hannover, Germany - bionity.com
The Cytonet Group is active in the field of medical biotechnology. It develops, produces and markets new, cell-based medical products. Cytonet's partners are leading international โฆSee details»
Cytonet GmbH & Co. Heidelberg Management KG, Heidelberg
Die Visualisierungen zu "Cytonet GmbH & Co. Heidelberg Management KG, Heidelberg" werden von North Data zur Weiterverwendung unter einer Creative Commons Lizenz zur Verfügung โฆSee details»
Cytonet: Hier pulsiert die deutsche Wirtschaft - pharma-zeitung.de
Jul 2, 2010 Über die Cytonet GmbH & Co. KG Die Cytonet-Gruppe ist ein international tätiges Biotech Unternehmen mit Standorten in Weinheim, Heidelberg und Durham (North Carolina, โฆSee details»
Joint Venture von Universitätsklinikum Heidelberg und Cytonet โฆ
Sep 29, 2000 Erstmals in seiner Geschichte beteiligt sich das Klinikum an einer Unternehmensgründung - Unter Verwendung menschlicher Zellen werden Therapieprodukte โฆSee details»
cytoNet - The BRAIN Initiative Alliance
To study complex tissue, cell and subcellular topologies, cytoNet integrates vision science with graph theory to quantify environmental effects on network topology. cytoNet applications โฆSee details»
Cytonet GmbH & Co. KG - BioCentury Company Profiles - BCIQ
Jun 22, 2018 Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.See details»
Cytonet Hannover GmbH - Hannover, Deutschland - bionity.com
Dec 15, 2005 Die Cytonet-Gruppe ist auf dem Gebiet der medizinischen Biotechnologie tätig. Sie entwickelt, produziert und vermarktet neue, zellbasierte, medizinische Produkte. Partner โฆSee details»
Cytonet GmbH & Co. KG: Fortschritt bei der Behandlung seltener โฆ
Mar 19, 2013 Cytonet arbeitet dabei in enger Kooperation mit international führenden neonatologischen und pädiatrischen Stoffwechselzentren. Das generelle Ziel ist eine wirksame โฆSee details»